Weekly versus daily iron during pregnancy.

Randomized Control Trial comparing efficacy of weekly versus daily antenatal oral iron supplementation in preventing anaemia during pregnancy.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2014/032

Enrollment

Unknown

Registered

2014-11-21

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron supplementation in pregnancy

Interventions

Consenting participants meeting inclusion/exclusion criteria will be randomized into two arms. Arm 1 - Ferrous sulfate 200 mg (Elemental iron 60 mg) + Folic acid 1 mg + Ascorbic acid 100 mg administe

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women between 12 to 20 weeks gestation 2. Hb > 11 g/dl , irrespective of the serum ferritin (SF) level.

Exclusion criteria

Exclusion criteria: 1. Pregnant women who are diagnosed to have hematological disorders 2. Pregnant women who are diagnosed to have any chronic diseases

Design outcomes

Primary

Measure	Time frame
1. Haemoglobin 2. PCV 3. Serum Ferritin [Between 34-36 weeks of gestation]	—

Secondary

Measure	Time frame
1. Compliance and the tolerance rates of the two regimens (assessed by tablet count and questionnaire) 2. Birth weight of baby. [1. At each clinic visit until delivery 2. At delivery]	—

Countries

Sri Lanka

Contacts

Public ContactProfessor Malik Goonewardene

Senior Professor & Head

malikg@eureka.lkTel: +94 91 2246878

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026